HUTCHMED (China) Limited (HCM) Q4 2024 Earnings Call Transcript

2025-03-19 12:17:59 ET

HUTCHMED (China) Limited (HCM)

Q4 2024 Earnings Conference Call

March 19, 2025 08:00 AM ET

Company Participants

David Ng - Head:IR

Wei-Guo Su - CEO & Chief Scientific Officer

Johnny Cheng - CFO

George Yuan - Head of Commercial

Michael Shi - EVP, Head of R&D & Chief Medical Officer

Conference Call Participants

Clara Dong - Jefferies

Alec Stranahan - Bank of America

Julie Simmonds - Panmure Liberum

Adam McCarter - Cavendish

Chen Chen - UBS

Cindy Chai - HSBC

Presentation

David Ng

Welcome, everyone. Thank you for joining HUTCHMED 2024 Full Year Results Call. Everyone is on listen-only mode at this stage. [Operator Instructions]

This information in the presentation will be also on our homepage where you can download the PowerPoint presentation as well. Should you experience any technical difficulties, please send a chat message in the chat box. This session will also be recorded and the recorded webcast will be posted on the platform in about a day or so. And just to go over some of the Safe Harbor Statement, the performance and results of operation of HUTCHMED contained within this presentation are all historical in nature and past performance is no guarantee of future results.

Forward-looking statements are based on current beliefs and expectations of management regarding future events and are subject to significant known and unknown risks and uncertainties. So one of these risks are materialized, any assumption may be proven to be incorrect, and actual results may vary from what was mentioned in the forward-looking statement. Today we will have a very good lineup of presentation.

First, our Chief Executive Officer, Chief Scientific Officer, Dr. Su, will have the opening, and then our Chief Financial Officer, Johnny Cheng, will go over the 2024 financial review and outlook. And then our Head of Commercial, George Yuan, will go over our commercial aspects. And that will be followed by our Head of R&D and Chief Medical Officer, Michael Shi to talk about our pipeline updates and also our new ATTC platform. And then we'll be followed by closing remarks by Dr. Su and then we will have the Q&A....

Read the full article on Seeking Alpha

For further details see: